MARÍA ISABEL
BLANCAS LÓPEZ-BARAJAS

PROFESORA ASOCIADA LABORAL

Foto de MARÍA ISABEL

Foto de Hospital Universitario 12 de Octubre

Hospital Universitario 12 de Octubre

Madrid, España

Publicaciones en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (4)

2024

Abemaciclib for treating patients with HR+/HER2- metastatic breast cancer: a real-world study in France, Italy and Spain
Future Oncology
Preventing alpelisib-related hyperglycaemia in HR+/HER2−/PIK3CA-mutated advanced breast cancer using metformin (METALLICA): a multicentre, open-label, single-arm, phase 2 trial
eClinicalMedicine, Vol. 71

2023

HOPE (SOLTI-1903) breast cancer study: real-world, patient-centric, clinical practice study to assess the impact of genomic data on next treatment decision-choice in patients with locally advanced or metastatic breast cancer
Frontiers in Oncology, Vol. 13

2014

Final results of a phase II study of paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer
Clinical and Translational Oncology, Vol. 17, Núm. 2, pp. 160-166